Deluxe increases receivables facility to $100M, extends to Dec 2028

DELUXE CORP

Facility limit increased to $100,000,000; Required Capital Amount raised to $17,500,000.
Scheduled Termination Date extended from March 2027 to December 14, 2028.
Drawn fee pricing set at 1.15% (Level II) based on current credit rating.
Amended Accrued Rebate Proxy to 42.72% and Deferred Revenue Proxy to 40.54%.
No other material changes; Performance Guaranty reaffirmed by Deluxe Corporation.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

DELUXE CORP amended Amendment No. 1 to Receivables Financing Agreement with MUFG Bank, Ltd., as administrative agent, and the group and agents and lenders party thereto valued at $100,000,000 (effective 2025-12-15).

Action: amendment
Agreement: credit facility
Counterparty: MUFG Bank, Ltd., as administrative agent, and the group and agents and lenders party thereto
Value: $100,000,000
Effective: 2025-12-15

Exact text from the filing

On December 15, 2025 (the “Closing Date”), Deluxe Receivables LLC (“Borrower”), a special purpose company and wholly-owned subsidiary of Deluxe Corporation (the “Company”), a Minnesota corporation, entered into Amendment No. 1 to Receivables Financing Agreement (the “Amendment”), amending the Receivables Financing Agreement, dated as of March 13, 2024 (the “RFA”) among MUFG Bank, Ltd., as administrative agent (the “Administrative Agent”), the Borrower, the Company, as initial servicer (the “Servicer”) and the group and agents and lenders party thereto.

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

DELUXE CORP filing history →

Source: SEC EDGAR

accession 0001104659-25-121857

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.